Plurality of anxiety and depression alteration mechanism by oleanolic acid
- 11 June 2014
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 28 (10) , 923-934
Abstract
Our study sought to evaluate the anxiolytic and antidepressant activities of oleanolic acid as well as the neural mechanisms involved. Animal models such as barbiturate sleep-induction, light–dark box, elevated plus maze, forced swimming test, tail suspension test and open field test were conducted. Male Albino Swiss mice were treated orally with vehicle 10 mL/kg, fluoxetine 20 mg/kg, imipramine 15 mg/kg, diazepam 1 mg/kg or oleanolic acid 5–40 mg/kg. Pretreatment (intraperitoneal) of animals with pentylenetetrazole (PTZ) 20 mg/kg, 1-(2-methoxyphenyl)-4-[4- (2-phthalimido) butyl]piperazine hydrobromide (NAN-190) 0.5 mg/kg, p-chlorophenylalanine methyl ester (PCPA) 100 mg/kg or α-methyl-p-tyrosine (AMPT) 100 mg/kg, WAY100635 (WAY) 0.3 mg/kg, prazosin (PRAZ) 1 mg/kg, yohimbine 2 mg/kg as well as monoamine oxidase assay and hippocampal brain-derived neurotrophic factor (BDNF) quantification were carried out. Oleanolic acid potentiated the hypnotic effect of barbiturate and demonstrated an anxiolytic effect in both the light–dark box and elevated plus maze. This effect was not reversed by PTZ. Acute and/or chronic oral treatment of mice with oleanolic acid (5−20 mg/kg) elicited an antidepressant effect in the forced swimming test and the tail suspension test without interfering with the locomotor activity. The antidepressant effect of oleanolic acid was attenuated by NAN-190, AMPT, PCPA, WAY and PRAZ. Although monoamine oxidase activity remained unaltered by oleanolic acid, chronic administration of oleanolic acid augmented hippocampal BDNF level. These findings demonstrate multiple mechanisms of the anxiolytic and antidepressant effect of oleanolic acid.Keywords
This publication has 48 references indexed in Scilit:
- Antidepressive-Like Property of Dichloromethane Fraction ofPimenta pseudocaryophyllusand Relevance of Monoamine Metabolic EnzymesEvidence-Based Complementary and Alternative Medicine, 2013
- Statistics, probability, significance, likelihood: words mean what we define them to meanBritish Journal of Pharmacology, 2011
- New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative StressJournal of Natural Products, 2011
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.Journal of Affective Disorders, 2009
- New insights into BDNF function in depression and anxietyNature Neuroscience, 2007
- Platforms and networks in triterpenoid pharmacologyDrug Development Research, 2007
- Biosynthesis of oleanolic acid and its glycosides in Calendula officinalis suspension culturePlant Physiology and Biochemistry, 2003
- A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxietyPharmacology Biochemistry and Behavior, 1996
- Anti-inflammatory activity of oleanolic acid in rats and miceJournal of Pharmacy and Pharmacology, 1992